Mumbai, May 26 -- Lupin has entered into a license and supply agreement with SteinCares, a leading specialty healthcare company in Latin America, for commercialization of Lupin's biosimilar ranibizumab across Latin America excluding Mexico and Argentina.

Published by HT Digital Content Services with permission from Capital Market....